Sanchez-Urdazpal L, Gores G J, Ward E M, Maus T P, Buckel E G, Steers J L, Wiesner R H, Krom R A
Section of Transplantation Surgery, Mayo Clinic, Rochester, Minnesota 55905.
Hepatology. 1993 Apr;17(4):605-9. doi: 10.1002/hep.1840170413.
The clinical significance and outcome of nonanastomotic strictures and dilatations involving only the biliary tree of the graft with a radiological appearance of biliary ischemia is unknown. Therefore we analyzed the grafts of 128 patients to evaluate the biochemical, radiological and histological features that prompted the diagnosis of ischemic-type biliary stricture and the clinical outcome of this complication. Ischemic-type biliary strictures were diagnosed in 25 patients (19%). Initial graft function was similar in all patients, whether or not this complication developed. Most ischemic-type biliary strictures occurred between 1 and 4 mo after orthotopic liver transplantation. However, the appearance of ischemic-type biliary stricture in the month after transplantation was predictive for a poor outcome in all six grafts with early onset of ischemic-type biliary strictures. Eighteen patients (72%) were treated with biliary stents and repeated dilatations. Long-term patency was achieved in 88% of these patients. Repeat transplantation was performed in six patients (24%); five survived. Finally, patients with ischemic-type biliary strictures spent more time in the hospital during the first year after orthotopic liver transplantation than did patients without the complication (62 +/- 27 days vs. 37 +/- 20 days; p < or = 0.001). This was due to repeated hospitalizations and a higher incidence of retransplantation. One-year graft survival was lower in patients with ischemic-type biliary strictures than in patients without ischemic-type biliary strictures (69% vs. 88%; p = 0.006). However, 1-yr patient survival was similar in the two groups (91% vs. 89%). In conclusion, early appearance of ischemic-type biliary stricture features is associated with poor graft prognosis.(ABSTRACT TRUNCATED AT 250 WORDS)
仅累及移植肝胆管树且放射学表现为胆管缺血的非吻合口狭窄及扩张的临床意义和结局尚不清楚。因此,我们分析了128例患者的移植肝,以评估促使诊断缺血型胆管狭窄的生化、放射学和组织学特征以及该并发症的临床结局。25例患者(19%)被诊断为缺血型胆管狭窄。无论是否发生这种并发症,所有患者的初始移植肝功能相似。大多数缺血型胆管狭窄发生在原位肝移植后1至4个月。然而,在移植后第一个月出现缺血型胆管狭窄对所有六例早期发生缺血型胆管狭窄的移植肝预后不良具有预测性。18例患者(72%)接受了胆管支架置入和反复扩张治疗。这些患者中有88%实现了长期通畅。6例患者(24%)接受了再次移植;5例存活。最后,原位肝移植后第一年,缺血型胆管狭窄患者的住院时间比无此并发症的患者更长(62±27天对37±20天;p≤0.001)。这是由于反复住院和再次移植的发生率较高。缺血型胆管狭窄患者的1年移植肝存活率低于无缺血型胆管狭窄的患者(69%对88%;p = 0.006)。然而,两组的1年患者存活率相似(91%对89%)。总之,缺血型胆管狭窄特征的早期出现与移植肝预后不良相关。(摘要截断于250字)